PL108111B1 - Method of producing optically active antipodes of sposob wytwarzania optycznie czynnych antypodow n-n-/2-benzhydryloethylo/-n-/1-phenyloethylo/amines /2-benzhydryloetylo/-n-/1-fenyloetylo-/amin,i ich soli and salts thereof - Google Patents
Method of producing optically active antipodes of sposob wytwarzania optycznie czynnych antypodow n-n-/2-benzhydryloethylo/-n-/1-phenyloethylo/amines /2-benzhydryloetylo/-n-/1-fenyloetylo-/amin,i ich soli and salts thereof Download PDFInfo
- Publication number
- PL108111B1 PL108111B1 PL1975197355A PL19735575A PL108111B1 PL 108111 B1 PL108111 B1 PL 108111B1 PL 1975197355 A PL1975197355 A PL 1975197355A PL 19735575 A PL19735575 A PL 19735575A PL 108111 B1 PL108111 B1 PL 108111B1
- Authority
- PL
- Poland
- Prior art keywords
- optically active
- benzhydryloethylo
- fenn
- active antipodes
- amines
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C211/00—Compounds containing amino groups bound to a carbon skeleton
- C07C211/01—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms
- C07C211/26—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms of an unsaturated carbon skeleton containing at least one six-membered aromatic ring
- C07C211/27—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms of an unsaturated carbon skeleton containing at least one six-membered aromatic ring having amino groups linked to the six-membered aromatic ring by saturated carbon chains
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Emergency Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| HUCI1510A HU169507B (en, 2012) | 1974-09-25 | 1974-09-25 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL108111B1 true PL108111B1 (pl) | 1980-03-31 |
Family
ID=10994536
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL1975197355A PL108111B1 (pl) | 1974-09-25 | 1975-09-24 | Method of producing optically active antipodes of sposob wytwarzania optycznie czynnych antypodow n-n-/2-benzhydryloethylo/-n-/1-phenyloethylo/amines /2-benzhydryloetylo/-n-/1-fenyloetylo-/amin,i ich soli and salts thereof |
| PL1975183553A PL107557B1 (pl) | 1974-09-25 | 1975-09-24 | Sposob wytwarzania optycznie czynnych antypod n-/2-benzhydryloetylo/-n-/1-fenyloetylo/-amin i ich soli |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL1975183553A PL107557B1 (pl) | 1974-09-25 | 1975-09-24 | Sposob wytwarzania optycznie czynnych antypod n-/2-benzhydryloetylo/-n-/1-fenyloetylo/-amin i ich soli |
Country Status (22)
| Country | Link |
|---|---|
| JP (1) | JPS5159843A (en, 2012) |
| AR (2) | AR210586A1 (en, 2012) |
| AT (1) | AT337675B (en, 2012) |
| AU (1) | AU497358B2 (en, 2012) |
| BE (1) | BE833824A (en, 2012) |
| CH (2) | CH609323A5 (en, 2012) |
| CS (2) | CS186749B2 (en, 2012) |
| DD (1) | DD124874A5 (en, 2012) |
| DE (1) | DE2541184C2 (en, 2012) |
| DK (1) | DK429075A (en, 2012) |
| FI (1) | FI752595A7 (en, 2012) |
| FR (1) | FR2285865A1 (en, 2012) |
| GB (1) | GB1464209A (en, 2012) |
| HU (1) | HU169507B (en, 2012) |
| IL (1) | IL48120A (en, 2012) |
| IN (1) | IN141186B (en, 2012) |
| NL (1) | NL7511183A (en, 2012) |
| NO (1) | NO753246L (en, 2012) |
| PL (2) | PL108111B1 (en, 2012) |
| SE (1) | SE7510611L (en, 2012) |
| SU (2) | SU603331A3 (en, 2012) |
| YU (2) | YU37112B (en, 2012) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0000896B1 (en) * | 1977-08-19 | 1982-10-13 | Sandoz Ag | Propenyl amines, processes for their production and pharmaceutical compositions containing them |
| FR2504524A1 (fr) * | 1981-04-22 | 1982-10-29 | Spofa Vereinigte Pharma Werke | N-(1-phenylethyl)-n-(3,3-diphenylpropyl)-hydroxylamines et procede pour leur preparation |
| US5763569A (en) * | 1991-08-23 | 1998-06-09 | The Brigham And Women's Hospital, Inc | Calcium receptor-active molecules |
| US6313146B1 (en) | 1991-08-23 | 2001-11-06 | Nps Pharmaceuticals, Inc. | Calcium receptor-active molecules |
| US6031003A (en) * | 1991-08-23 | 2000-02-29 | Nps Pharmaceuticals, Inc. | Calcium receptor-active molecules |
| US6011068A (en) * | 1991-08-23 | 2000-01-04 | Nps Pharmaceuticals, Inc. | Calcium receptor-active molecules |
| US6001884A (en) * | 1991-08-23 | 1999-12-14 | Nps Pharmaceuticals, Inc. | Calcium receptor-active molecules |
| US5858684A (en) * | 1991-08-23 | 1999-01-12 | The Brigham And Women's Hospital, Inc. | Method of screening calcium receptor-active molecules |
| US5962314A (en) * | 1993-02-23 | 1999-10-05 | Nps Pharmaceuticals, Inc. | Calcium receptor-active molecules |
| PL183499B1 (pl) * | 1994-10-21 | 2002-06-28 | Nps Pharma Inc | Związki do modulowania receptorów wapniowych i kompozycje farmaceutyczne |
| US6057346A (en) * | 1994-12-12 | 2000-05-02 | The United States Of America As Represented By The Department Of Health And Human Services | Inhibition of retroviral LTR promoters by calcium response modifiers |
| DE69722934T2 (de) | 1996-05-01 | 2004-05-27 | NPS Pharmaceuticals, Inc., Salt Lake City | Verbindungen , die auf anorganische ionen-rezeptoren wirken |
| US20150344407A1 (en) * | 2012-08-21 | 2015-12-03 | The Board Of Regents Of The University Of Texas System | Fendiline derivatives and methods of use thereof |
| RU2739376C1 (ru) * | 2020-07-24 | 2020-12-23 | Федеральное государственное бюджетное учреждение науки Институт элементоорганических соединений им. А.Н. Несмеянова Российской академии наук (ИНЭОС РАН) | Способ получения фендилина |
-
1974
- 1974-09-25 HU HUCI1510A patent/HU169507B/hu unknown
-
1975
- 1975-09-16 DE DE2541184A patent/DE2541184C2/de not_active Expired
- 1975-09-16 CS CS7700003090A patent/CS186749B2/cs unknown
- 1975-09-16 CS CS7500006278A patent/CS186718B2/cs unknown
- 1975-09-17 FI FI752595A patent/FI752595A7/fi not_active Application Discontinuation
- 1975-09-17 AT AT711175A patent/AT337675B/de active
- 1975-09-17 IL IL48120A patent/IL48120A/xx unknown
- 1975-09-18 IN IN1788/CAL/1975A patent/IN141186B/en unknown
- 1975-09-18 AU AU84956/75A patent/AU497358B2/en not_active Expired
- 1975-09-22 SE SE7510611A patent/SE7510611L/xx not_active Application Discontinuation
- 1975-09-23 DD DD188496A patent/DD124874A5/xx unknown
- 1975-09-23 FR FR7529069A patent/FR2285865A1/fr active Granted
- 1975-09-23 NL NL7511183A patent/NL7511183A/xx not_active Application Discontinuation
- 1975-09-23 JP JP50115476A patent/JPS5159843A/ja active Pending
- 1975-09-24 YU YU2394/75A patent/YU37112B/xx unknown
- 1975-09-24 DK DK429075A patent/DK429075A/da unknown
- 1975-09-24 PL PL1975197355A patent/PL108111B1/pl unknown
- 1975-09-24 AR AR260504A patent/AR210586A1/es active
- 1975-09-24 PL PL1975183553A patent/PL107557B1/pl unknown
- 1975-09-24 CH CH950277A patent/CH609323A5/xx not_active IP Right Cessation
- 1975-09-24 CH CH1237175A patent/CH596139A5/xx not_active IP Right Cessation
- 1975-09-24 NO NO753246A patent/NO753246L/no unknown
- 1975-09-24 GB GB3915075A patent/GB1464209A/en not_active Expired
- 1975-09-25 SU SU752174852A patent/SU603331A3/ru active
- 1975-09-25 BE BE160382A patent/BE833824A/xx not_active IP Right Cessation
-
1976
- 1976-08-03 SU SU762386655A patent/SU837319A3/ru active
- 1976-11-26 AR AR265488A patent/AR211558A1/es active
-
1981
- 1981-11-04 YU YU2611/81A patent/YU37115B/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| YU37115B (en) | 1984-08-31 |
| YU239475A (en) | 1983-04-27 |
| AR211558A1 (es) | 1978-01-30 |
| CS186749B2 (en) | 1978-12-29 |
| FR2285865B1 (en, 2012) | 1980-05-30 |
| FI752595A7 (en, 2012) | 1976-03-26 |
| DK429075A (da) | 1976-03-26 |
| IL48120A0 (en) | 1975-11-25 |
| ATA711175A (de) | 1976-11-15 |
| HU169507B (en, 2012) | 1976-12-28 |
| CH596139A5 (en, 2012) | 1978-02-28 |
| JPS5159843A (en) | 1976-05-25 |
| DD124874A5 (en, 2012) | 1977-03-16 |
| AT337675B (de) | 1977-07-11 |
| SU837319A3 (ru) | 1981-06-07 |
| CH609323A5 (en) | 1979-02-28 |
| AU8495675A (en) | 1977-03-24 |
| AU497358B2 (en) | 1978-12-07 |
| NL7511183A (nl) | 1976-03-29 |
| YU37112B (en) | 1984-08-31 |
| IL48120A (en) | 1979-05-31 |
| YU261181A (en) | 1983-04-27 |
| AR210586A1 (es) | 1977-08-31 |
| NO753246L (en, 2012) | 1976-03-26 |
| DE2541184C2 (de) | 1984-05-10 |
| FR2285865A1 (fr) | 1976-04-23 |
| DE2541184A1 (de) | 1976-04-15 |
| SE7510611L (sv) | 1976-03-26 |
| CS186718B2 (en) | 1978-12-29 |
| SU603331A3 (ru) | 1978-04-15 |
| IN141186B (en, 2012) | 1977-01-29 |
| GB1464209A (en) | 1977-02-09 |
| BE833824A (fr) | 1976-01-16 |
| PL107557B1 (pl) | 1980-02-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR100292592B1 (ko) | 세로토닌길항제로서의n-시아노n'-피리딜구아니딘 | |
| PL108111B1 (pl) | Method of producing optically active antipodes of sposob wytwarzania optycznie czynnych antypodow n-n-/2-benzhydryloethylo/-n-/1-phenyloethylo/amines /2-benzhydryloetylo/-n-/1-fenyloetylo-/amin,i ich soli and salts thereof | |
| JPH09504535A (ja) | 新規ベンゾイルグアニジン誘導体、その調製及び医薬組成物における使用 | |
| JPH054983A (ja) | イソキノリノン誘導体、その製造方法およびその誘導体を有効成分として含有する５−ｈｔ３ レセプター拮抗剤 | |
| WO1996037474A1 (en) | Sulfonylquinolines as neuropeptide y1 antagonists | |
| MXPA06000850A (es) | Compuesto de acido ciclohexancarboxilico. | |
| JPS6136282A (ja) | 窒素を含む複素環式化合物からなる医薬品とその製造方法 | |
| CZ9202002A3 (en) | Pyrimidine-4-carboxamide derivatives, process of their preparation and pharmaceutical compositions in which said derivatives are comprised | |
| RU1797610C (ru) | Способ получени (2-морфолинофенил)гуанидинов или их фармацевтически приемлемых солей | |
| SU1238732A3 (ru) | Способ получени 6-хлор-3-метил-2,3,4,5-тетрагидро-1 @ -3-бензазепина или его гидрохлорида | |
| JPH02138266A (ja) | ６‐フェニル‐３‐（ピペラジニルアルキル）‐２，４（１ｈ，３ｈ）‐ピリミジンジオン誘導体 | |
| EP0314363A2 (en) | Anti-anxiety agents | |
| JPS6039678B2 (ja) | 新規インド−ル誘導体の製法 | |
| DK156722B (da) | Analogifremgangsmaade til fremstilling af 2-piperazinopyrimidinderivater | |
| US4556739A (en) | 3,4-Dialkoxy-2-alkylcarbonyl analino compounds | |
| US4632940A (en) | N-substituted 1-(4'-alkylsulfonylphenyl)-2-amino-1,3-propanediols, pharmaceutical compositions containing them, having local anesthetic activity | |
| US5096900A (en) | (4-piperidyl)methyl-2,3-dihydro-1h-isoindole and -2,3,4,5-tetrahydro-1h-benzazepine derivatives, their preparation and their application in therapy | |
| JPS63165362A (ja) | 置換アミノチメル−５，６，７，８−テトラヒドロナフチルオキシ酢酸類、中間体類、それらの製造法および薬物におけるそれらの使用 | |
| US4994465A (en) | Antihyperlipidemic and antiatherosclerotic trisubstituted urea compounds | |
| US5472966A (en) | Antidepressant heteroarylaminoalkyl derivatives of naphthyl-monazines | |
| IL25315A (en) | O-(2-guanidino-ethyl)-oximes | |
| EP2029580B1 (de) | Neue indol-pyrrol-derivate zur behandlung proliferativer und inflammatorischer krankheiten | |
| US5081128A (en) | 2,3-dihydro-1h-isoindole derivatives and their application in therapy | |
| JP2546919B2 (ja) | ９ーアシルアミノテトラヒドロアクリジン誘導体 | |
| JPH05201978A (ja) | Ｎ−（４，７−ジメトキシ−２−インダニル）−１−（フェニルカルボニル）−ｎ−プロピル−４−ピペリジンメタンアミン誘導体、その製造法および医薬への応用 |